Company / SG&A per Share
Vanda Pharmaceuticals Inc. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.94
FY2025
5-year range
$1.94 / $2.51
FY2021-FY2025
Trend
-18.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share has fluctuated over the past 10 years, ranging from $1.92 in FY2017 to $2.51 in FY2022.
Based on SEC 10-K filings.
1.94 in FY2025 with a 5-year CAGR of -0.4%.
Improved from $2.18 to $1.94 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -8.3%
- 5-Year CAGR
- -0.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, sg&a per share decreased 18.4% year-over-year.
- Peak sg&a per share was recorded in FY2022.
- Lowest sg&a per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -3.96 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.94 | -18.4% |
| FY2024 | $2.37 | +8.6% |
| FY2023 | $2.18 | -13.1% |
| FY2022 | $2.51 | +6.3% |
| FY2021 | $2.36 | +19.7% |
| FY2020 | $1.97 | -16.3% |
| FY2019 | $2.36 | +6.3% |
| FY2018 | $2.22 | +15.6% |
| FY2017 | $1.92 | -2.8% |
| FY2016 | $1.98 | +227.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026